CalciMedica
CALC
13 hedge funds and large institutions have $1.56M invested in CalciMedica in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
1.53% less ownership
Funds ownership: 11.99% → 10.46% (-1.5%)
43% less capital invested
Capital invested by funds: $2.72M → $1.56M (-$1.16M)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $791K | – | – | – |
|
2
Hudson Bay Capital Management
Stamford,
Connecticut
| $432K | +$553K | +166,857 | New |
|
|
BCM
3
BML Capital Management
Zionsville,
Indiana
| $236K | – | – | – |
|
4
First Manhattan
New York
| $35.2K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $34.6K | +$44.3K | +13,354 | New |
|
|
MPM
6
Meritage Portfolio Management
Overland Park,
Kansas
| $27K | – | – | – |
|
7
Morgan Stanley
New York
| $4.14K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $1.16K | +$1.4K | +422 | +3,014% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $955 | -$5.61K | -1,691 | -90% |
|
10
Bank of America
Charlotte,
North Carolina
| $80 | +$96 | +29 | +2,900% |
|
11
Wells Fargo
San Francisco,
California
| $40 | +$3 | +1 | +7% |
|
12
Qube Research & Technologies (QRT)
London,
United Kingdom
| $3 | +$3 | +1 | New |
|
|
DM
13
Deerfield Management
New York
| – | -$1.07M | -265,657 | Closed |
|
|
NA
14
NewEdge Advisors
New Orleans,
Louisiana
| – | -$285 | -71 | Closed |
|
|
GI
15
Gradient Investments
Arden Hills,
Minnesota
| – | -$52 | -13 | Closed |
|
CALC Hedge Fund Activity: Q3 2023 in Review
13 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2023, worth a combined $1.56M — down 43% from $2.72M a quarter earlier.
Fund positioning in CALC was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $553K. The largest seller was Deerfield Management, exiting entirely with an estimated $1.07M sold.
- 13 institutional investors held CalciMedica (CALC) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $1.56M of CalciMedica stock for Q3 2023, down 43% quarter-over-quarter.
- 3 funds opened new CalciMedica positions in Q3 2023 and 3 closed out, a net change of 0 holders.
- The largest CalciMedica buyer in Q3 2023 was Hudson Bay Capital Management, an estimated $553K added.
- The largest CalciMedica seller in Q3 2023 was Deerfield Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q3 2023.